Every diagnosis we work toward is grounded in a measurement. These are the signals our pipeline reads — spectral power, neural firing, network coupling, and modelled stimulation fields.
Absolute and relative power across δ, θ, α, β and γ bands — and the ratios that track psychiatric presentations.
Spike-train dynamics across channels — the raster view of when and where the brain is active over time.
Phase-locking and coherence between regions — isolating the hyper- and hypo-connected hubs behind symptoms.
Individually modelled tDCS current flow — optimising the montage before a single electrode is placed.
How do distributed brain networks produce cognition, emotion, behaviour — and psychiatric illness? Each division attacks a different facet, from computation to the clinic.
Predictive ML models, symptom-network analysis, digital phenotyping, and Bayesian & reinforcement-learning cognitive models — the engine of precision psychiatry.
Attention, executive function, working memory, cognitive flexibility, inhibition, decision-making, emotion regulation, and learning — including neuropsychological models of ADHD.
Functional and dynamic connectivity, oscillatory networks, connectomics, and network biomarkers of large-scale brain systems.
How oscillatory interactions among distributed networks generate cognition, emotion, and symptoms — applied across OCD, depression, ADHD, bipolar, schizophrenia, autism, anxiety, and functional neurological disorders.
Development and validation of EEG, qEEG, neurofeedback, tDCS, tACS, tVNS, and digital biomarkers.
Treatment-outcome studies, biomarkers, psychopharmacology, psychotherapy, neuromodulation, and longitudinal cohorts.
Smartphone monitoring, passive sensing, digital phenotyping, remote assessment, and AI-assisted care.
Objective behavioural phenotyping — including the structure of personality and temperament — through naturalistic and task-based paradigms, behavioural biomarkers, and behaviour-change studies that link observable action to cognition, emotion, and network dynamics.
Divisions share data, methods, and a single pipeline — so a biomarker found in one becomes a tool for all.
Measurable biological and cognitive markers for diagnosis.
Matching patients to the most effective treatment using objective data.
Disorders as disturbances of distributed neural networks.
Illness understood through abnormalities in brain oscillations.
EEG, cognition, AI and dynamic network analysis, combined.
A staged build-out of the physical and computational infrastructure the institute's research requires.
Clinical EEG, qEEG, brain-stimulation and physiological recording systems.
Computerised testing — Stroop, N-back, Go/No-Go, task-switching, SART, reaction-time and executive-function batteries.
AI models, statistical pipelines, machine-learning systems, network-analysis tools, and simulations.
Digital biomarkers, smartphone tools, AI clinical assistants, and patient-monitoring systems.
Studies of medication, psychotherapy, neuromodulation, and biomarker-guided precision treatment.
An Institutional Ethics Committee, data-governance framework, responsible-AI policy, and patient-privacy standards underpin every lab.
Biomarkers for depression, OCD, ADHD, psychosis, anxiety, and bipolar disorder.
Objective cognitive phenotyping using computerised tasks.
Mapping dynamic oscillatory interactions in psychiatric disorders.
Optimising brain stimulation using biomarkers.
Large-scale predictive models integrating clinical data, EEG, cognition, psychometrics, and longitudinal outcomes.
We're in setup — these are the first, concrete projects we're building. Each is tagged with its honest current stage.
Building the EEG acquisition and automated preprocessing pipeline, and computing our first quantitative biomarkers on real patient data.
Mapping dynamic oscillatory interactions across disorders — the groundwork for our signature research theme.
Objective, task-based and naturalistic behavioural measures — building behavioural biomarkers alongside the cognitive and EEG work.
Mapping personality structure and temperament to objective markers — linking trait dimensions with cognition, emotion regulation, and brain-network dynamics.
Formal cognitive and computational models of attention, inhibition and executive control in ADHD — tied to EEG and behavioural biomarkers.
Biomarker-guided, individually modelled tDCS — turning network findings into optimised, personalised stimulation.
A research data registry and predictive models integrating clinical data, EEG, cognition, behaviour, and longitudinal outcomes.
We publish our stage honestly. Projects move from concept → planning → setup → active as the institute matures.